Literature DB >> 2077342

Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia.

R Gupta1, J W Yewdell, R A Olmsted, P L Collins, J R Bennink.   

Abstract

Effector cells capable of lysing respiratory syncytial virus (RSV)-infected cells were isolated from the lungs of intranasally infected mice. An examination of their specificity showed that cytolysis was major histocompatibility complex restricted. Using recombinant vaccinia viruses containing cloned RSV genes to infect target cells, BALB/c (H-2d) pulmonary effector cells were shown to recognize the fusion protein (F) and to a lesser extent the nucleoprotein (N). Cells specific for the major glycoprotein (G) or the small hydrophobic protein (1A) were not observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2077342     DOI: 10.1016/0882-4010(90)90036-p

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  3 in total

1.  Cell-mediated immune responses of lambs to challenge with bovine respiratory syncytial virus.

Authors:  A K Sharma; Z Woldehiwet
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.

Authors:  M Connors; A B Kulkarni; C Y Firestone; K L Holmes; H C Morse; A V Sotnikov; B R Murphy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.

Authors:  A B Kulkarni; M Connors; C Y Firestone; H C Morse; B R Murphy
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.